What does FIMOVAR do?

FIMOVAR is a pharmacy in Niel. Public Limited, started on 7 January 1998, 1 establishment.

What is the address of FIMOVAR?

The registered office of FIMOVAR is located at Heideplaats 42, 2845 Niel.

Is FIMOVAR still active?

Yes. According to the CBE (30 October 2026) FIMOVAR is active, legal situation “Normale toestand”, started on 7 January 1998.

Is FIMOVAR registered on Peppol?

Yes, FIMOVAR is registered on the Peppol network with ID 0208:0462346837.

What is the enterprise number of FIMOVAR?

The enterprise number of FIMOVAR is BE0462346837.

When was FIMOVAR founded?

FIMOVAR was founded on 7 January 1998.

Who are the directors of FIMOVAR?

According to the 2025 annual accounts, the directors of FIMOVAR are: Eva Van Reeth, Filip Moens.

Is FIMOVAR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 January 1998; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did FIMOVAR make in 2025?

FIMOVAR posted a profit after taxes of € 278,546 in financial year 2025.

What is the revenue of FIMOVAR?

As a small company, FIMOVAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 338,725.

How many employees does FIMOVAR have?

According to the 2025 annual accounts, FIMOVAR has 0.4 full-time equivalents (FTE).

FIMOVAR (Public Limited) - Niel - BE0462346837

Dossier FIMOVAR, printed on 30 October 2026 from databakkes.be/en/0462346837/fimovar. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 6 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

FIMOVAR from Niel, company number BE0462346837, closed financial year 2025 with a result of € 278,546 after tax. For that financial year FIMOVAR recorded a gross margin of € 338,725 and equity of € 1.6 million. Compared with financial year 2024, the result moved from € 264,114 to € 278,546. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 1.6 million

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 278,546

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 180

▲ € 158 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.5 million.

People and assets in 2025

Full-time equivalents

0.4

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 30,988

▲ 16% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 781,697

▼ 10% vs 2024

€ 115,222 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 10,736

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 30,635

▲ 132% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 250,721 Gross margin 2022: € 250,721 First fiscal year in the series	€ 216,997 Gross margin 2023: € 216,997 ▼ 13% vs 2022 (€ 250,721) Unfavourable step	€ 303,440 Gross margin 2024: € 303,440 ▲ 40% vs 2023 (€ 216,997) Favourable step	€ 338,725 Gross margin 2025: € 338,725 ▲ 12% vs 2024 (€ 303,440) Favourable step	▲ 12%
Profit after taxes	€ 154,444 Profit after taxes 2022: € 154,444 First fiscal year in the series	€ 131,981 Profit after taxes 2023: € 131,981 ▼ 15% vs 2022 (€ 154,444) Unfavourable step	€ 264,114 Profit after taxes 2024: € 264,114 ▲ 100% vs 2023 (€ 131,981) Favourable step	€ 278,546 Profit after taxes 2025: € 278,546 ▲ 5% vs 2024 (€ 264,114) Favourable step	▲ 5%
Equity	€ 934,078 Equity 2022: € 934,078 First fiscal year in the series	€ 1,066,059 Equity 2023: € 1,066,059 ▲ 14% vs 2022 (€ 934,078) Favourable step	€ 1,330,173 Equity 2024: € 1,330,173 ▲ 25% vs 2023 (€ 1,066,059) Favourable step	€ 1,608,720 Equity 2025: € 1,608,720 ▲ 21% vs 2024 (€ 1,330,173) Favourable step	▲ 21%
Total debts	€ 2,717,144 Total debts 2022: € 2,717,144 First fiscal year in the series	€ 2,479,189 Total debts 2023: € 2,479,189 ▼ 9% vs 2022 (€ 2,717,144) Favourable step	€ 2,268,767 Total debts 2024: € 2,268,767 ▼ 8% vs 2023 (€ 2,479,189) Favourable step	€ 1,923,057 Total debts 2025: € 1,923,057 ▼ 15% vs 2024 (€ 2,268,767) Favourable step	▼ 15%
Cash	€ 19 Cash 2022: € 19 First fiscal year in the series	€ 32 Cash 2023: € 32 ▲ 67% vs 2022 (€ 19) Favourable step	€ 22 Cash 2024: € 22 ▼ 32% vs 2023 (€ 32) Unfavourable step	€ 180 Cash 2025: € 180 ▲ € 158 vs 2024 (€ 22) Favourable step	▲ € 158
Land & buildings	€ 1,217,922 Land & buildings 2022: € 1,217,922 First fiscal year in the series	€ 1,153,414 Land & buildings 2023: € 1,153,414 ▼ 5% vs 2022 (€ 1,217,922) Unchanged	€ 1,110,655 Land & buildings 2024: € 1,110,655 ▼ 4% vs 2023 (€ 1,153,414) Unchanged	€ 1,048,377 Land & buildings 2025: € 1,048,377 ▼ 6% vs 2024 (€ 1,110,655) Unchanged	▼ 6%
Retained profit	€ 867,146 Retained profit 2022: € 867,146 First fiscal year in the series	€ 999,128 Retained profit 2023: € 999,128 ▲ 15% vs 2022 (€ 867,146) Favourable step	€ 1,263,242 Retained profit 2024: € 1,263,242 ▲ 26% vs 2023 (€ 999,128) Favourable step	€ 1,541,788 Retained profit 2025: € 1,541,788 ▲ 22% vs 2024 (€ 1,263,242) Favourable step	▲ 22%
Bank debt	€ 1,082,304 Bank debt 2022: € 1,082,304 First fiscal year in the series	€ 974,914 Bank debt 2023: € 974,914 ▼ 10% vs 2022 (€ 1,082,304) Favourable step	€ 871,882 Bank debt 2024: € 871,882 ▼ 11% vs 2023 (€ 974,914) Favourable step	€ 781,697 Bank debt 2025: € 781,697 ▼ 10% vs 2024 (€ 871,882) Favourable step	▼ 10%
Balance sheet total	€ 3,651,221 Balance sheet total 2022: € 3,651,221 First fiscal year in the series	€ 3,545,248 Balance sheet total 2023: € 3,545,248 ▼ 3% vs 2022 (€ 3,651,221) Unchanged	€ 3,598,941 Balance sheet total 2024: € 3,598,941 ▲ 2% vs 2023 (€ 3,545,248) Unchanged	€ 3,531,777 Balance sheet total 2025: € 3,531,777 ▼ 2% vs 2024 (€ 3,598,941) Unchanged	▼ 2%
Employees (FTE)	0.2 Employees (FTE) 2022: 0.2 First fiscal year in the series	0.3 Employees (FTE) 2023: 0.3 ▲ 0.1 vs 2022 (0.2) Unchanged	0.4 Employees (FTE) 2024: 0.4 ▲ 0.1 vs 2023 (0.3) Unchanged	0.4 Employees (FTE) 2025: 0.4 Unchanged (0.4) Unchanged

Key figures of FIMOVAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to FIMOVAR?

What happened at FIMOVAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Eva Van Reeth stepped down as director. NBB
2029 Filip Moens stepped down as director. NBB
Jul 29, 2026 New annual accounts for financial year 2025: profit of € 278,546 (▲ 5% vs 2024). Source: NBB ↗
Jun 2, 1998 New establishment in Niel. KBO
Jan 7, 1998 Start of the company according to the CBE. KBO

In short

From € 154,444 profit in 2022 to € 278,546 profit in 2025.

Paid € 140,846 in corporate taxes since 2022.

Best year ever: 2025, with € 278,546 profit.

Original PDFs at the National Bank ↗

Management

FIMOVAR

Apotheek MOENS-MAMPAEY 100%

Apotheek Moens Mortsel 100%

Apotheek Moens Niel 99.2%

It owns 100% of Apotheek MOENS-MAMPAEY, 100% of Apotheek Moens Mortsel and 99.2% of Apotheek Moens Niel itself.

Directors

According to the 2025 annual accounts

Eva Van Reeth

Bestuurder

Also active at: APOTHEEK MOENS NIEL

· until 2029

Filip Moens

Bestuurder

Also active at: APOTHEEK MOENS NIEL, Apotheek MOENS-MAMPAEY

· until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Heideplaats 42

2845 Niel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

APOTHEEK MOENS NIEL same network

€ 560,140 gross margin · 2025

Groep Fimovar

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0462.346.837

VAT number

BE 0462.346.837

Registered office

Heideplaats 42, 2845 Niel

Names & denominations

FIMOVAR

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

7 January 1998

Peppol

Active · Active since 14 Nov 2024

Activities · NACE

Detailhandel in farmaceutische producten

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

View on CBE Public ↗ Annual accounts (NBB) ↗

FIMOVAR

Warning lights

Financials

What happened to FIMOVAR?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions